Clinical Trials Logo

Clinical Trial Summary

The primary objective is to determine if the Smartphone electrocardiogram (ECG) is an acceptable replacement for a standard ECG in the identification of ST elevation myocardial infarction (STEMI).


Clinical Trial Description

Toward this objective, this study involves the following:

- Obtain simultaneous recordings of a standard 12-lead ECG and the iPhone "12-lead equivalent" ECG on patients presenting with chest pain in which the STEMI protocol was activated.

- Obtain simultaneous recordings of a standard 12-lead ECG and the iPhone "12-lead equivalent" ECG on patients presenting to the Emergency Department for evaluation of chest pain, not necessarily presenting with STEMI.

- Reading of ECGs (standard 12-lead and iPhone) by three independent cardiologists, who are blinded to the initial clinical ECG readings, the type of ECG equipment used, and the patient's clinical information.

- Assess the operational feasibility of using the Smartphone to obtain "12-lead equivalent" ECG recordings in patients suspected to have STEMI, and

- Determine the possibility of pooling the data obtained from this study with data from other institutions conducting identical studies, and developing a future IRB-approved protocol and statistical analysis plan to compare the sensitivity, specificity, positive predictive value and the negative predictive power of the iPhone ECG, using a paired standard 12-lead ECG as the gold standard.

There will be no therapeutic interventions. A single research-related procedure will be required, i.e. an iPhone ECG. Effort will be made to ensure that the performance of this procedure will not delay any treatment and/or diagnostic procedures that are part of usual or specialized care that the patient requires. Effort will be made to enroll 1 STEMI patient for every 2 non-STEMI patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04057404
Study type Observational
Source INTEGRIS Baptist Medical Center
Contact
Status Completed
Phase
Start date September 2015
Completion date July 30, 2018

See also
  Status Clinical Trial Phase
Completed NCT04183140 - Comparison of Radial and Ulnar Artery Intervention in Patients With ST Elevated Myocardial Infarction N/A
Recruiting NCT04002739 - PRedictOrs, PHEnotypes and Timing of Obstructive Sleep Apnea in Acute Coronary Syndrome N/A
Recruiting NCT05211401 - Rituximab in Patients With ST-elevation Myocardial Infarction Phase 2
Recruiting NCT05491200 - Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients Phase 4
Completed NCT01663194 - Neutrophil/Lymphocyte (N/L) Ratio and Long Term Follow-up in ST-elevation Myocardial Infarction N/A
Recruiting NCT05752617 - European Registry On Plaque ModifiCAtion in the STEMI Population (ROCA-STEMI)
Completed NCT04887571 - the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry